Form 4: Arteris CFO Executes Pre-Arranged Stock Sale Under 10b5-1 Plan

Nicholas B. Hawkins, VP and Chief Financial Officer of Arteris, Inc., reported the sale of 3,770 shares of common stock on June 9, 2025, as part of a pre-scheduled 10b5-1 trading plan.

Summary

• Nicholas B. Hawkins, the Vice President and Chief Financial Officer of Arteris, Inc. (AIP), reported a transaction involving the company's common stock.
• On June 9, 2025, Mr. Hawkins disposed of 3,770 shares of Arteris, Inc. common stock.
• The shares were sold at a weighted average price of $8.0651 per share, with individual transactions ranging from $8.01 to $8.13.
• This transaction was executed pursuant to a Rule 10b5-1 trading plan, which was adopted by Mr. Hawkins on May 20, 2024.
• Following this sale, Mr. Hawkins beneficially owns 161,937 shares of Arteris, Inc. common stock directly.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a pre-planned sale under a 10b5-1 plan, which is a common practice for executives managing personal liquidity and not typically indicative of a change in company outlook.

Positives

• The transaction was conducted under a Rule 10b5-1 trading plan, indicating a pre-scheduled sale for liquidity or diversification purposes rather than a reaction to new, non-public information.

Negatives

• The sale by a key executive, even if pre-planned, reduces the direct equity alignment of management with shareholders, though the number of shares sold is relatively small compared to total holdings.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This Form 4 filing is specific to an insider transaction at Arteris, Inc. and does not provide broader industry trends or competitive analysis.

Stakeholder Impact

• Shareholders: The sale slightly reduces the direct equity stake of a key executive, which could be perceived as a minor reduction in alignment, but the pre-planned nature mitigates negative signaling.

Key Dates

Keywords

Arteris Inc., AIP, Form 4, Insider Trading, Stock Sale, 10b5-1 Plan, Nicholas B. Hawkins, Beneficial Ownership